BPC-157 & TB-500 Blend (5mg+5mg)

This blend combines BPC-157 5mg and TB-500 5mg in a single vial, both peptides synthesized and lyophilized in the USA. Each batch is purified by multiple rounds of high-performance liquid chromatography and verified by mass spectrometry, with HPLC-MS purity above 99% and independent third-party certificates published for every lot. Supplied as lyophilized powder for in-vitro laboratory research use only.

Each vial of BPC-157 & TB-500 Blend (5mg+5mg) contains a pre-weighed ratio of BPC-157 5mg, TB-500 5mg in a single lyophilized cake, simplifying multi-peptide research protocols.

Laboratory work on BPC-157 & TB-500 Blend (5mg+5mg) emphasizes reproducible dosing and purity verification before experimental application.

Current literature on BPC-157 & TB-500 Blend (5mg+5mg) explores its stability profile and bioactivity under defined buffer and temperature conditions.

BPC-157 & TB-500 Blend (5mg+5mg) is a focus of tissue-repair research, where it is evaluated for its effects on cellular recovery processes in model systems.

Each vial contains lyophilized peptide at the labeled quantity, and wholesale orders are packed in boxes of ten vials at a single per-vial price.

Quality assurance: every batch is purified by reversed-phase high-performance liquid chromatography and identity-confirmed by mass spectrometry, with purity above 99%. Lot-specific certificates of analysis are available on request. Store lyophilized vials at -20°C, protected from light and moisture; reconstitute with bacteriostatic water immediately before use and avoid repeated freeze-thaw cycles. For in-vitro laboratory research use only — not for human or veterinary use.

Research & Literature

The following peer-reviewed studies and reference documents are commonly consulted by researchers working with BPC-157 & TB-500 Blend (5mg+5mg). Summaries are provided for orientation only and reflect the cited sources.

The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration^[1] — This study investigated the effects of the pentadecapeptide BPC 157 on tendon healing in an experimental model. The authors reported that BPC 157 promoted tendon outgrowth, cell survival, and cell migration, processes central to tissue repair. These findings indicated that BPC 157 may accelerate functional healing of injured tendons. (Journal of Applied Physiology 2011)

The pharmacological properties of the novel peptide BPC 157 (PL-10)^[2] — This review described the pharmacological properties of the novel pentadecapeptide BPC 157, also designated PL-10. It summarized the peptide's protective and healing-promoting activities across gastrointestinal and other organ systems. The authors framed BPC 157 as a stable peptide with broad cytoprotective potential. (Inflammopharmacology 1999)

Thymosin beta 4 Promotes Dermal Healing^[3] — This review examined the role of thymosin beta 4 in promoting dermal wound healing. It discussed the peptide's actin-binding motif, which is also present in the TB-500 fragment, and its effects on cell migration and tissue repair. The authors highlighted thymosin beta 4's potential as a therapeutic agent for cutaneous wounds. (Vitamins and Hormones 2016)

Thymosin beta 4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and suppression of the Toll-like proinflammatory pathway^[4] — This study investigated a signaling mechanism through which thymosin beta 4 promotes oligodendrocyte differentiation. The authors reported that thymosin beta 4 up-regulates microRNA-146a, leading to suppression of the Toll-like receptor proinflammatory pathway. These findings suggested that thymosin beta 4 may support neural repair by modulating both inflammatory and differentiation signals. (Journal of Biological Chemistry 2014)

References

1. Chang CH, et al.. "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." Journal of Applied Physiology. 2011. pubmed.ncbi.nlm.nih.gov/21030672/
2. Sikiric P. "The pharmacological properties of the novel peptide BPC 157 (PL-10)." Inflammopharmacology. 1999. pubmed.ncbi.nlm.nih.gov/17657443/
3. Kleinman HK, Sosne G. "Thymosin beta 4 Promotes Dermal Healing." Vitamins and Hormones. 2016. pubmed.ncbi.nlm.nih.gov/27450738/
4. Santra M, et al.. "Thymosin beta 4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and suppression of the Toll-like proinflammatory pathway." Journal of Biological Chemistry. 2014. doi.org/10.1074/jbc.M113.529966

All products are supplied as lyophilized powder for in-vitro laboratory research use only and are not for human or veterinary use.